Everything in BCI.
One portal.

Every change in the field, the day it happens, with its source.

• Clinical, regulatory, capital, hiring, research, code and policy events
• What it means, for the way you follow the field
• How sure we are: observed, declared or inferred

All sources below

The companies, devices, people and repositories you name — and an alert when they move.

• Unlimited entities across every module
• Same-day, daily or weekly
• Dashboard, email, private repository or API

Your choices

Every story in the field, as it breaks, with its source.

• Companies, research, clinic and policy
• Filtered by your watchlist
• Each item linked to its source

Primary sources and the press

The quarterly report on the whole field.

• Implants, trials, approvals and capital
• What changed, and why it matters
• Every figure cited

Everything in Radar Next

Every company building BCIs: what they build, how far they are, who is behind them.

• Modality, indication and stage
• Programmes, trials and approvals
• Founders and team, from public sources
• Hiring mix and open roles

Registries, filings, company sites

Who invests in BCI, how often, at what stage, and alongside whom.

• Rounds by fund, with co-investors
• Stage and modality focus
• Follow-on behaviour

SEC filings, announcements

Every implant, headset and interface: what it records, how many channels, where it stands.

• Invasive, minimally invasive and non-invasive
• Channels, signal, sampling and power
• Regulatory status and clinical stage

Regulators, papers, manufacturers

The field on one page, by modality and market — and how it shifts each quarter.

• Medical and consumer
• Invasive to wearable
• Quarter over quarter

Derived from the modules above

Every disclosed round, year by year, and the money that has not been announced yet.

• Rounds, amounts and lead investors
• Year to date against prior years
• Filings before announcements

Filings and announcements

Every brain–computer interface device, side by side, filterable.

• Type, channels and signal
• Regulatory status and stage
• Manufacturer and country

Regulators, papers, manufacturers

Who records from the most channels — and how much of it is demonstrated.

• Channel counts by device
• Demonstrated against declared
• Per modality

Papers and manufacturers

Any two companies, side by side.

• Modality, stage and channels
• Trials, approvals and capital
• Hiring and research output

Every module above

Companies, labs and trials, by country and hub.

• Countries and cities
• Clinical sites
• Where hiring grows

Registries, company records

How many people carry an investigational brain implant, by programme — and how we know.

• Count by programme, with its source
• Implants per quarter
• Peer-reviewed or company-reported

Papers, registries, company reports

The programmes nearest a regulatory decision, by enrollment.

• Enrolled against target
• Estimated completion
• Pathway: feasibility to pivotal

Trial registries

How many tracked devices are cleared or approved, and for what.

• 510(k), De Novo and PMA
• Breakthrough designations
• By modality

Regulators' databases

Who is in humans, how fast, and where — from the registries themselves.

• Feasibility to pivotal
• Enrollment, target against actual
• Sites, status changes, results posted

ClinicalTrials.gov and international registries

Who may sell what, and where.

• FDA 510(k), De Novo, PMA and Breakthrough
• CE marking and other regions
• Predicate devices and product codes

openFDA, regulators' databases

What happens to brain data, and which laws protect it.

• What each consumer product sends, keeps and shares
• Policy changes, the day they happen
• Neural-data laws by jurisdiction

Company policies, legislatures

The formats and standards the field is converging on.

• ISO/IEC, IEEE and community standards
• Who implements which
• Drafts, ballots and publications

Standards bodies, source code

What has been demonstrated — not just announced.

• Peer-reviewed and preprint, marked apart
• Results by company, device and method
• Landmark papers, explained

PubMed, arXiv, bioRxiv

The people and labs behind the results.

• Principal investigators by topic
• Collaborations and output
• Where they publish, who they work with

Publication records

Open recordings to build and test on.

• Paradigm, subjects, channels, format
• Licence and access
• Quality, examined

Open data repositories

Where the effort is going before it ships.

• Grants and publications by assignee
• By technical class
• Twelve-month velocity

Patent offices

The open software of the field, mapped and scored every three hours.

• Tools, SDKs and pipelines
• What works with which device, verified in code
• Releases, maintainers and adoption

GitHub, package registries

The libraries everyone depends on, and which are going quiet.

• Days since the last change
• Active maintainers
• Who depends on them

GitHub

Who is hiring, for what — and what that says about where they are going.

• Open roles by function
• Mix over time
• Remote and on site

Companies' own job boards

Where the field meets.

• Conferences, workshops, meetups
• Deadlines and calls
• Who is speaking

Organisers

A century of brain–computer interfaces, from the first EEG to today.

• Milestones, dated and sourced
• Firsts in humans
• Approvals

Public record

The field explained, from first principles, for anyone.

• Invasive and non-invasive, explained
• A glossary of the field
• What is real today

Our editors

Every headline number, graded by the evidence behind it.

• Channels, speed, latency, accuracy, patients
• Regulator, peer review, preprint or the company's word
• Supported, partially, or not established

The sources it cites

Your question, answered by an analyst, with every figure cited.

• Ten to fourteen pages
• Your scope
• Five business days

Everything above

Everything in your dashboard, as data.

• JSON API
• CSV and NDJSON exports
• Webhooks

This dashboard